Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25132143 | 0.83 | TAAR1 (0.58) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25132031 | 0.83 | TAAR1 (0.58) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25132274 | 0.82 | TAAR1 (0.51) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL28496847 | 0.81 | SMN1; SMN2 (0.56) | SMN1; SMN2POLBMEN1KMT2AHSD17B10 | |
| SCHEMBL3565815 | 0.80 | SMN1; SMN2 (0.60) | SMN1; SMN2MEN1KMT2AHPGDHSD17B10 | |
| SCHEMBL24883838 | 0.79 | CA1 (0.41) | SMN1; SMN2POLBMEN1KMT2AHPGD | |
| SCHEMBL25022061 | 0.79 | SMN1; SMN2 (0.49) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL30932891 | 0.78 | SMN1; SMN2 (0.75) | SMN1; SMN2MEN1KMT2AHPGDHSD17B10 | |
| SCHEMBL5305354 | 0.78 | TAAR1 (0.63) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25905935 | 0.78 | CA1 (0.40) | SMN1; SMN2POLBHPGDTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6946547-B2 | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds | MICROGENICS CORPORATION (US) | 2005-09-20 | — | — | US | disclosed |
| US-20030207469-A1 | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds | MICROGENICS CORPORATION (US) | 2003-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207469-A1 | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds | CES2, DNPEP, HLA-A | TAAR1 359/4885SLC6A2 240/4885SLC6A4 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.